Sarepta Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Sarepta Therapeutics (NASDAQ:SRPT) will participate in three upcoming virtual investor conferences in March 2022. These include:

• Cowen 42nd Annual Health Care Conference on March 9, 2022, at 2:10 p.m. E.T.
• Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022, at 3:20 p.m. E.T.
• Guggenheim 3rd Annual Genomic Medicines and Rare Disease Day on March 31, 2022, at 12 p.m. E.T.

The presentations will be available via live webcast on Sarepta's website and archived for 90 days. The company focuses on precision genetic medicine for rare diseases.

CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at three upcoming virtual investor conferences:

• Cowen 42^nd Annual Health Care Conference on Wednesday, March 9, 2022 at 2:10 p.m. E.T.
• Oppenheimer 32^nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 3:20 p.m. E.T.
• Guggenheim 3^rd Annual Genomic Medicines and Rare Disease Day on Thursday, March 31, 2022 at 12 p.m. E.T.
  

The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com

FAQ

What conferences will Sarepta Therapeutics (SRPT) attend in March 2022?

Sarepta Therapeutics will attend the Cowen 42nd Annual Health Care Conference on March 9, the Oppenheimer 32nd Annual Healthcare Conference on March 15, and the Guggenheim 3rd Annual Genomic Medicines and Rare Disease Day on March 31.

When is the Cowen 42nd Annual Health Care Conference for Sarepta (SRPT)?

The Cowen 42nd Annual Health Care Conference will take place on March 9, 2022, at 2:10 p.m. E.T.

How can I watch the presentations from Sarepta Therapeutics (SRPT)?

Presentations from Sarepta Therapeutics will be available via live webcast on their website and archived for 90 days.

What is the focus of Sarepta Therapeutics (SRPT)?

Sarepta Therapeutics specializes in precision genetic medicine for rare diseases, with a significant focus on Duchenne muscular dystrophy and limb-girdle muscular dystrophies.

Where can I find more information about Sarepta Therapeutics (SRPT)?

More information about Sarepta Therapeutics can be found on their official website at www.sarepta.com.